107
Participants
Start Date
April 30, 2015
Primary Completion Date
October 28, 2019
Study Completion Date
October 28, 2019
Carfilzomib
Administered once weekly by 30-minute intravenous (IV) infusion on days 1, 8, and 15 of each 28-day cycle.
Lenalidomide
Administered orally once daily on days 1-21 of each 28-day cycle.
Dexamethasone
Administered by mouth or IV at 40 mg on days 1, 8, and 15 of each 28-day cycle and on day 22 of cycles 1 to 8.
Research Site, New York
Research Site, New York
Research Site, Stony Brook
Research Site, Washington D.C.
Research Site, Durham
Research Site, Charleston
Research Site, Greenville
Research Site, West Palm Beach
Research Site, Tampa
Research Site, Fort Myers
Research Site, Nashville
Research Site, Nashville
Research Site, Germantown
Research Site, Cincinnati
Research Site, Ann Arbor
Research Site, Wauwatosa
Research Site, Sioux Falls
Research Site, Aurora
Research Site, Salt Lake City
Research Site, Los Angeles
Research Site, Whittier
Research Site, Burbank
Research Site, Fountain Valley
Research Site, Bakersfield
Research Site, Bend
Research Site, Seattle
CBCC Global Research, Inc. at Comprehensive Blood and Cancer Center, Bakersfield
Providence Saint Joseph Medical Center, Burbank
Compassionate Care Research Group, Inc., Fountain Valley
Los Angeles Hematology / Oncology Medical Group, Los Angeles
University of Colorado, Aurora
Lombardi Cancer Center, Pediatric Hematology Oncology, Washington D.C.
Florida Cancer Specialists, Fort Myers
H. Lee Moffitt Cancer Center & Research Institute, Tampa
Florida Cancer Specialists, West Palm Beach
University of Chicago Medical Center, Chicago
Dana Farber Partners Cancer Care, Boston
John Theurer Cancer Center at Hackensack University Medical Center, Hackensack
Clinical Research Alliance, New York
Memorial Sloan Kettering, New York
Morton Coleman, MD, New York
Weill Cornell Medical College, New York
Stony Brook University Medical Center, Stony Brook
Durham Veterans Affairs Medical Center, Durham
Sarah Cannon Research Institute, Cincinnati
Bend Memorial Clinic, Bend
Medical University of South Carolina, Hollings Cancer Center, Charleston
Greenville Health System, Greenville
Saint Francis Hospital Cancer Center, Greenville
Avera Cancer Institute, Sioux Falls
The West Clinic, PC, Memphis
Tennessee Oncology, PLLC / The Sarah Cannon Research lnstitute, Nashville
Vanderbilt University Medical Center, Nashville
Huntsman Cancer Institute, Salt Lake City
Swedish Cancer Institute, Seattle
Aurora Health Care, Aurora Cancer Care, Milwaukee
Research Site, Los Angeles
Research Site, Boston
Research Site, Hackensack
Lead Sponsor
Amgen
INDUSTRY